Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy

Ding Ai, Wei Pang, Nan Li, Ming Xu, Paul D. Jones, Jun Yang, Youyi Zhang, Nipavan Chiamvimonvat, John Y J Shyy, Bruce D. Hammock, Yi Zhu

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Pathophysiological cardiac hypertrophy is one of the most common causes of heart failure. Epoxyeicosatrienoic acids, hydrolyzed and degraded by soluble epoxide hydrolase (sEH), can function as endothelium-derived hyperpolarizing factors to induce dilation of coronary arteries and thus are cardioprotective. In this study, we investigated the role of sEH in two rodent models of angiotensin II (Ang II)-induced cardiac hypertrophy. The protein level of sEH was elevated in the heart of both spontaneously hypertensive rats and Ang II-infused Wistar rats. Blocking the Ang II type 1 receptor with losartan could abolish this induction. Administration of a potent sEH inhibitor (sEHI) prevented the pathogenesis of the Ang II-induced hypertrophy, as demonstrated by decreased left-ventricular hypertrophy assessed by echocardiography, reduced cardiomyocyte size, and attenuated expression of hypertrophy markers, including atrial natriuretic factor and β-myosin heavy chain. Because sEH elevation was not observed in exercise- or norepinephrine-induced hypertrophy, the sEH induction was closely associated with Ang II-induced hypertrophy. In vitro, Ang II upregulated sEH and hypertrophy markers in neonatal cardiomyocytes isolated from rat and mouse. Expression of these marker genes was elevated with adenovirus-mediated sEH overexpression but decreased with sEHI treatment. These results were supported by studies in neonatal cardiomyocytes from sEH -/- mice. Our results suggest that sEH is specifically upregulated by Ang II, which directly mediates Ang II-induced cardiac hypertrophy. Thus, pharmacological inhibition of sEH would be a useful approach to prevent and treat Ang II-induced cardiac hypertrophy.

Original languageEnglish (US)
Pages (from-to)564-569
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume106
Issue number2
DOIs
StatePublished - Jan 13 2009

Fingerprint

Epoxide Hydrolases
Cardiomegaly
Angiotensin II
Hypertrophy
Cardiac Myocytes
Angiotensin Type 1 Receptor
Losartan
Myosin Heavy Chains
Left Ventricular Hypertrophy
Atrial Natriuretic Factor
Inbred SHR Rats
Adenoviridae
Endothelium
Echocardiography
Wistar Rats
Dilatation
Rodentia
Coronary Vessels
Norepinephrine
Heart Failure

Keywords

  • Activator protein 1
  • Cardiomyocyte
  • Epoxyeicosatrienoic acid

ASJC Scopus subject areas

  • General

Cite this

Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. / Ai, Ding; Pang, Wei; Li, Nan; Xu, Ming; Jones, Paul D.; Yang, Jun; Zhang, Youyi; Chiamvimonvat, Nipavan; Shyy, John Y J; Hammock, Bruce D.; Zhu, Yi.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 2, 13.01.2009, p. 564-569.

Research output: Contribution to journalArticle

Ai, Ding ; Pang, Wei ; Li, Nan ; Xu, Ming ; Jones, Paul D. ; Yang, Jun ; Zhang, Youyi ; Chiamvimonvat, Nipavan ; Shyy, John Y J ; Hammock, Bruce D. ; Zhu, Yi. / Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. In: Proceedings of the National Academy of Sciences of the United States of America. 2009 ; Vol. 106, No. 2. pp. 564-569.
@article{fa06c64fd4cb4092900ad98bd99df543,
title = "Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy",
abstract = "Pathophysiological cardiac hypertrophy is one of the most common causes of heart failure. Epoxyeicosatrienoic acids, hydrolyzed and degraded by soluble epoxide hydrolase (sEH), can function as endothelium-derived hyperpolarizing factors to induce dilation of coronary arteries and thus are cardioprotective. In this study, we investigated the role of sEH in two rodent models of angiotensin II (Ang II)-induced cardiac hypertrophy. The protein level of sEH was elevated in the heart of both spontaneously hypertensive rats and Ang II-infused Wistar rats. Blocking the Ang II type 1 receptor with losartan could abolish this induction. Administration of a potent sEH inhibitor (sEHI) prevented the pathogenesis of the Ang II-induced hypertrophy, as demonstrated by decreased left-ventricular hypertrophy assessed by echocardiography, reduced cardiomyocyte size, and attenuated expression of hypertrophy markers, including atrial natriuretic factor and β-myosin heavy chain. Because sEH elevation was not observed in exercise- or norepinephrine-induced hypertrophy, the sEH induction was closely associated with Ang II-induced hypertrophy. In vitro, Ang II upregulated sEH and hypertrophy markers in neonatal cardiomyocytes isolated from rat and mouse. Expression of these marker genes was elevated with adenovirus-mediated sEH overexpression but decreased with sEHI treatment. These results were supported by studies in neonatal cardiomyocytes from sEH -/- mice. Our results suggest that sEH is specifically upregulated by Ang II, which directly mediates Ang II-induced cardiac hypertrophy. Thus, pharmacological inhibition of sEH would be a useful approach to prevent and treat Ang II-induced cardiac hypertrophy.",
keywords = "Activator protein 1, Cardiomyocyte, Epoxyeicosatrienoic acid",
author = "Ding Ai and Wei Pang and Nan Li and Ming Xu and Jones, {Paul D.} and Jun Yang and Youyi Zhang and Nipavan Chiamvimonvat and Shyy, {John Y J} and Hammock, {Bruce D.} and Yi Zhu",
year = "2009",
month = "1",
day = "13",
doi = "10.1073/pnas.0811022106",
language = "English (US)",
volume = "106",
pages = "564--569",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "2",

}

TY - JOUR

T1 - Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy

AU - Ai, Ding

AU - Pang, Wei

AU - Li, Nan

AU - Xu, Ming

AU - Jones, Paul D.

AU - Yang, Jun

AU - Zhang, Youyi

AU - Chiamvimonvat, Nipavan

AU - Shyy, John Y J

AU - Hammock, Bruce D.

AU - Zhu, Yi

PY - 2009/1/13

Y1 - 2009/1/13

N2 - Pathophysiological cardiac hypertrophy is one of the most common causes of heart failure. Epoxyeicosatrienoic acids, hydrolyzed and degraded by soluble epoxide hydrolase (sEH), can function as endothelium-derived hyperpolarizing factors to induce dilation of coronary arteries and thus are cardioprotective. In this study, we investigated the role of sEH in two rodent models of angiotensin II (Ang II)-induced cardiac hypertrophy. The protein level of sEH was elevated in the heart of both spontaneously hypertensive rats and Ang II-infused Wistar rats. Blocking the Ang II type 1 receptor with losartan could abolish this induction. Administration of a potent sEH inhibitor (sEHI) prevented the pathogenesis of the Ang II-induced hypertrophy, as demonstrated by decreased left-ventricular hypertrophy assessed by echocardiography, reduced cardiomyocyte size, and attenuated expression of hypertrophy markers, including atrial natriuretic factor and β-myosin heavy chain. Because sEH elevation was not observed in exercise- or norepinephrine-induced hypertrophy, the sEH induction was closely associated with Ang II-induced hypertrophy. In vitro, Ang II upregulated sEH and hypertrophy markers in neonatal cardiomyocytes isolated from rat and mouse. Expression of these marker genes was elevated with adenovirus-mediated sEH overexpression but decreased with sEHI treatment. These results were supported by studies in neonatal cardiomyocytes from sEH -/- mice. Our results suggest that sEH is specifically upregulated by Ang II, which directly mediates Ang II-induced cardiac hypertrophy. Thus, pharmacological inhibition of sEH would be a useful approach to prevent and treat Ang II-induced cardiac hypertrophy.

AB - Pathophysiological cardiac hypertrophy is one of the most common causes of heart failure. Epoxyeicosatrienoic acids, hydrolyzed and degraded by soluble epoxide hydrolase (sEH), can function as endothelium-derived hyperpolarizing factors to induce dilation of coronary arteries and thus are cardioprotective. In this study, we investigated the role of sEH in two rodent models of angiotensin II (Ang II)-induced cardiac hypertrophy. The protein level of sEH was elevated in the heart of both spontaneously hypertensive rats and Ang II-infused Wistar rats. Blocking the Ang II type 1 receptor with losartan could abolish this induction. Administration of a potent sEH inhibitor (sEHI) prevented the pathogenesis of the Ang II-induced hypertrophy, as demonstrated by decreased left-ventricular hypertrophy assessed by echocardiography, reduced cardiomyocyte size, and attenuated expression of hypertrophy markers, including atrial natriuretic factor and β-myosin heavy chain. Because sEH elevation was not observed in exercise- or norepinephrine-induced hypertrophy, the sEH induction was closely associated with Ang II-induced hypertrophy. In vitro, Ang II upregulated sEH and hypertrophy markers in neonatal cardiomyocytes isolated from rat and mouse. Expression of these marker genes was elevated with adenovirus-mediated sEH overexpression but decreased with sEHI treatment. These results were supported by studies in neonatal cardiomyocytes from sEH -/- mice. Our results suggest that sEH is specifically upregulated by Ang II, which directly mediates Ang II-induced cardiac hypertrophy. Thus, pharmacological inhibition of sEH would be a useful approach to prevent and treat Ang II-induced cardiac hypertrophy.

KW - Activator protein 1

KW - Cardiomyocyte

KW - Epoxyeicosatrienoic acid

UR - http://www.scopus.com/inward/record.url?scp=58849115391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849115391&partnerID=8YFLogxK

U2 - 10.1073/pnas.0811022106

DO - 10.1073/pnas.0811022106

M3 - Article

C2 - 19126686

AN - SCOPUS:58849115391

VL - 106

SP - 564

EP - 569

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 2

ER -